Cart
sales@molnova.com
JNJ-40355003
CAS No. 1394894-41-7
JNJ-40355003( —— )
Catalog No. M34296 CAS No. 1394894-41-7
JNJ-40355003 is a specific fatty acid amide hydrolase (FAAH) inhibitor that increases plasma levels of fatty acid amides in rats, dogs, and crabs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 244 | In Stock |
|
| 5MG | 221 | In Stock |
|
| 10MG | 354 | In Stock |
|
| 25MG | 710 | In Stock |
|
| 50MG | 1097 | In Stock |
|
| 100MG | 1758 | In Stock |
|
| 200MG | 2399 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJNJ-40355003
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-40355003 is a specific fatty acid amide hydrolase (FAAH) inhibitor that increases plasma levels of fatty acid amides in rats, dogs, and crabs.
-
DescriptionJNJ-40355003 is a potent and selective atty acid amide hydrolase (FAAH) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetFAAH
-
RecptorFAAH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1394894-41-7
-
Formula Weight422.91
-
Molecular FormulaC23H23ClN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC=1C=NC=CC1)N2CCN(CC=3C=CC=C(OC4=CC=C(Cl)C=C4)C3)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. John M Keith, et al. Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate. ACS Med Chem Lett. 2012 Aug 22;3(10):823-7.?
molnova catalog
related products
-
PF 750
PF 750 is a selective and covalent inhibitor of FAAH. PF 750 shows IC50s varying from 16.2 to 595 nM in different incubation times.
-
PDP-EA
PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.
-
VU534
VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.VU534 is a dual inhibitor of FAAH and sEH, with an IC50 of 1.2 μM for sEH.VU534 is used in diseases related to cardiometabolism.
